Rankings
▼
Calendar
TKNO Q4 2020 Earnings — Alpha Teknova, Inc. Revenue & Financial Results | Market Cap Arena
TKNO
Alpha Teknova, Inc.
$135M
Q4 2020 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$10M
Gross Profit
$6M
54.8% margin
Operating Income
$795,000
7.8% margin
Net Income
$577,000
5.7% margin
EPS (Diluted)
$0.03
QoQ Revenue Growth
+13.1%
Cash Flow
Operating Cash Flow
$2M
Free Cash Flow
-$1M
Stock-Based Comp.
$269,000
Balance Sheet
Total Assets
$63M
Total Liabilities
$11M
Stockholders' Equity
$52M
Cash & Equivalents
$3M
← FY 2020
All Quarters
Q1 2021 →